Background:
Polycystic Ovary Syndrome (PCOS) is a hormonal disorder characterized by elevated androgen levels, heightened insulin secretion, and dysregulation of Luteinizing Hormone and Follicle Stimulating Hormone. This disorder results in metabolic disruptions, while the irregular estrous cycles associated with PCOS impact cellular functions like growth, movement, and alterations in cell adhesion within the tissue matrix.
Aim:
This study aims to identify the blood tension, serum malondialdehyde (MDA) levels and serum MMP-1 in rat model of PCOS. The study was conducted using female Wistar rats aged 6 months weighing between 130-180 grams.
Methods:
The rats were divided into three treatment groups: negative control, induction of Testosterone Propionate (TP) at a dose of 100 mg/kg BW IP for 12 days, and induction of Estradiol Valerate (EV) at a dose of 2 mg/kg BW IP for 2 days. Data were analyzed quantitatively using one-way Analysis of Variance (ANOVA) followed by Posthoc Test using the Least Significant Difference with a confidence level of 95%.
Results:
The research results indicate that the average blood pressure of TP Group and EV Group did not differ significantly from the negative control (p>0.05). Serum MDA levels were significantly different in TP Group compared to the negative control (p0.05) among all the treatment groups.
Conclusion:
The findings of this study suggest that testosterone propionate induction in a rat model of PCOS can potentially contribute to oxidative stress and lipid peroxidation, but does not significantly affect blood pressure or serum MMP-1 levels.
Key words: PCOS, Blood-pressure, Animal models, MMP-1, Malondialdehyde
|
